Deutsche Bank AG purchased a new position in Envista Holdings Corporation (NYSE:NVST - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 359,824 shares of the company's stock, valued at approximately $9,481,000. Deutsche Bank AG owned about 0.22% of Envista at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. GSA Capital Partners LLP purchased a new position in Envista in the second quarter worth about $2,039,000. Dimensional Fund Advisors LP grew its holdings in shares of Envista by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company's stock valued at $248,130,000 after buying an additional 152,488 shares during the last quarter. SummitTX Capital L.P. purchased a new stake in shares of Envista during the first quarter valued at approximately $4,268,000. Principal Financial Group Inc. increased its position in shares of Envista by 36.8% during the first quarter. Principal Financial Group Inc. now owns 483,983 shares of the company's stock valued at $12,279,000 after acquiring an additional 130,237 shares in the last quarter. Finally, Intech Investment Management LLC bought a new stake in shares of Envista during the fourth quarter valued at approximately $2,501,000.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on NVST. JPMorgan Chase & Co. boosted their price objective on shares of Envista from $26.00 to $29.00 and gave the stock a "neutral" rating in a report on Thursday, May 7th. BMO Capital Markets began coverage on Envista in a research note on Wednesday, July 8th. They set a "market perform" rating and a $27.00 target price on the stock. Barclays reduced their target price on Envista from $34.00 to $32.00 and set an "overweight" rating for the company in a report on Thursday, June 11th. Weiss Ratings raised Envista from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, August 6th. Finally, Wall Street Zen raised Envista from a "buy" rating to a "strong-buy" rating in a research report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat, Envista has a consensus rating of "Moderate Buy" and an average price target of $29.31.
Get Our Latest Research Report on Envista
Envista Stock Up 0.0%
Shares of Envista stock opened at $27.21 on Monday. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. The company's 50 day moving average is $26.90 and its 200 day moving average is $26.30. The company has a market cap of $4.37 billion, a price-to-earnings ratio of 46.91, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86.
Envista (NYSE:NVST - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm's revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Research analysts anticipate that Envista Holdings Corporation will post 1.53 EPS for the current year.
Envista Company Profile
(
Free Report)
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Read More
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.